Fibrinogen Antibody (1F3) Summary
Fibrin degradation products.
Secreted
Fibrinogen, Fibrin degradation products.
IgG1
Monoclonal
Mouse
FGA
Protein A purified
Test in a species/application not listed above to receive a full credit towards a future purchase.
Learn about the Innovators Reward
Applications/Dilutions
- Western Blot 1:100-1:2000
- Sandwich ELISA 1:100-1:2000
Recommended pairs for sandwich immunoassay (capture-detection): NB120-10066 – NB200-420, NB120-10068 – NB120-10066, or NB100-73041 – NB120-10066
Reactivity Notes
Cross-reacts with Human.Not yet tested in other species.
Packaging, Storage & Formulations
Store at 4C. Do not freeze.
PBS
0.09% Sodium Azide
Protein A purified
Alternate Names for Fibrinogen Antibody (1F3)
- Factor I
- FGA
- FGB
- Fib2
- fibrinogen alpha chain
- Fibrinogen
- fibrinogen, A alpha polypeptide
- MGC119422
- MGC119423
- MGC119425
Background
Fibrinogen is the main protein of blood coagulation system. It is a large protein and it consists of two identical subunits that contain three polypeptide chains: alpha, beta and gamma. All chains are connected with each other by a number of disulfide bonds. Fibrinopeptides A (1 to 16 amino acids) and B (1 to 17 amino acids) are released by thrombin from the N terminal parts of alpha and beta chains, respectively. In this way fibrinogen is converted into fibrin, which by means of polymerization forms a fibrin clot. Fibrinogen clotting underlies pathogenesis of MI, thromboembolism and thromboses of arteries and veins, since fibrin is the main substrate for thrombus formation. Fibrinogen activation is also involved in pathogenesis of inflammation, tumor growth and many other diseases. The normal fibrinogen concentration in plasma is about 3 mg/ml. The elevated level of fibrinogen in patients blood is regarded as an independent risk factor for cardiovascular diseases. An increase in blood fibrinogen concentration was shown to be a strong predictor of coronary heart disease (Sonel A. et al, and Rapold H.J. et al). All these facts make fibrinogen an important parameter in the diagnosis of cardiovascular diseases.
Limitations
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
product targets :　LRRK2 inhibitors